[pending] CARVEDILOL (CARVEDILOL)
Pending LLM rewrite. Source: FDA_DRUG D-0336-2025.
- Product
- CARVEDILOL — CARVEDILOL (CARVEDILOL)
- Category
- Drug
- Distribution
- Distributed nationwide
State
20,072 recalls have nationwide distribution and so reach Virginia. 0 additional recalls listed Virginia specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Virginia consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DRUG D-0336-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0353-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0330-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0361-2025.
Medline is recalling 20 units of ReNewal Coblator II ENT devices because drip chambers may disconnect from saline tubing under tension, potentially disrupting fluid delivery during procedures.
Pending LLM rewrite. Source: FDA_DRUG D-0327-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0334-2025.
Glenmark Pharmaceuticals is recalling acetaminophen-ibuprofen tablets due to manufacturing quality deviations. No illnesses reported. Distributed nationwide via Amazon and Walmart.
Pending LLM rewrite. Source: FDA_DRUG D-0316-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0354-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0358-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0356-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0349-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0325-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0314-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0352-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0328-2025.
Glenmark Pharmaceuticals is recalling Lacosamide 150mg tablets nationwide due to manufacturing quality deviations. Consumers should contact their pharmacy or healthcare provider regarding their supply.
Pending LLM rewrite. Source: FDA_DEVICE Z-1548-2025.
Glenmark Pharmaceuticals is recalling Saxagliptin 2.5mg tablets nationwide due to manufacturing quality issues. The firm initiated this voluntary recall on March 13, 2025.
Asegua Therapeutics is recalling 18,541 cartons of Sofosbuvir and Velpatasvir tablets nationwide due to defective blister packs that are not properly sealed, resulting in loose tablets in cartons. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals is voluntarily recalling Indomethacin Extended-Release Capsules (75mg) distributed nationwide due to Good Manufacturing Practice deviations identified during FDA oversight.
Glenmark Pharmaceuticals is voluntarily recalling Saxagliptin 5mg tablets nationwide due to CGMP deviations. Affected lot numbers are 17232460 and 17241194.
Glenmark Pharmaceuticals is voluntarily recalling Prochlorperazine Maleate 10mg tablets (NDC# 68462-890-01) distributed nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals is voluntarily recalling Pravastatin Sodium 80mg tablets due to Current Good Manufacturing Practice deviations. The nationwide recall affects specific lot numbers and remains ongoing.